Neurology

Trofinetide shows promise for Rett syndrome in Phase 3 study

In a Phase 3 clinical trial, trofinetide, a synthetic analog of a specific protein, has shown promising results in treating the core symptoms of Rett syndrome, according to a study. The study demonstrated significant improvements in behavior, global impression, and communication abilities in individuals with Rett syndrome who received trofinetide...